Temporospatial quantification of fluorescein-labeled sinonasal irrigation delivery

Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA, USA.
International Forum of Allergy and Rhinology (Impact Factor: 2.37). 09/2011; 1(5):361-5. DOI: 10.1002/alr.20041
Source: PubMed

ABSTRACT Treatment of sinonasal disease is predicated on the delivery and retention of the agent at the desired location. Despite multiple distribution studies, there remains a need for a method capable quantifying not only the site and amount of agent deposition but the rate of clearance as well.
Five patients underwent endoscopic image capture of 3 subsites over 15 minutes following fluorescein-dyed irrigation using a squeeze bottle, nasal saline spray, or nasal gel spray. Area and intensity staining were quantified using a graphics editing program. Total intensity scores were compared using a Student t test.
The squeeze bottle was the only method demonstrating delivery to the oropharynx (37 ± 22 mm(2) ). The nasal gel resulted in the greatest coverage of the middle turbinate region (10 ± 15 mm(2) ) while the nasal saline spray (75 ± 31 mm(2) ) resulted in the greatest inferior turbinate coverage. No significant differences in clearance rates were found between delivery methods at any subsite.
This method is capable of quantifying both the area and intensity of fluorescein deposition using a variety of delivery methods. While small variations in subsite coverage were noted, all methods resulted in significant internal valve deposition. Despite differences in delivery volume and viscosity, all methods resulted in similar rates of fluorescein clearance.


Available from: Richard J Harvey, May 28, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The intricate pathophysiology of brain disorders, difficult access to the brain, and the complexity and high risks and costs of drug development represent major hurdles for improving therapies. Nose-to-brain drug transport offers an attractive alternative or addition to formulation-only strategies attempting to enhance drug penetration into the CNS. Although still a matter of controversy, many studies in animals claim direct nose-to-brain transport along the olfactory and trigeminal nerves, circumventing the traditional barriers to CNS entry. Some clinical trials in man also suggest nose-to-brain drug delivery, although definitive proof in man is lacking. This review focuses on new nasal delivery technologies designed to overcome inherent anatomical and physiological challenges and facilitate more efficient and targeted drug delivery for CNS disorders.
    Therapeutic delivery 06/2014; 5(6):709-733. DOI:10.4155/tde.14.41
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Mucosal Atomization Device (MAD) distributes medication throughout the paranasal sinuses for patients with chronic rhinosinusitis (CRS). Determining the optimal head position is important to ensure maximal delivery of medication to the sinus cavities. The objective of this work was to determine the effect of the lying-head-back (LHB) and head-down and forward (HDF) position, on the distribution of topical nasal medication via MAD in cadaver specimens. Twenty specimens having received complete functional endoscopic sinus dissection were chosen. The MAD was used to administer 2 mL of fluorescein-impregnated saline solution through the nose in both the LHB and HDF positions. Fluorescein was identified on 11 predetermined anatomical areas using a blue light filter. Three blinded investigators assessed endoscopic images to determine the presence of fluorescein. A total of 440 anatomical locations (n = 20 cadavers) received administration of the fluorescein nasal spray in the LHB or HDF position. LHB position had significantly greater total distribution to all pertinent anatomical sites than the HDF position (76% vs 41%; p < 0.001; 95% confidence interval [CI], 0.26-0.44). The proportion of staining was significantly greater for the ethmoid (p = 0.11; 95% CI, 0.05-0.66), frontal (p < 0.01; 95% CI, 0.20-0.80), and sphenoid sinuses (p = 0.03; 95% CI, 0.07-0.73) when compared to the HDF position. A greater distribution of medication to the sinonasal cavities was observed in the LHB position compared to the HDF position. These areas are of particular clinical relevance in postsurgical patients with refractory CRS.
    International Forum of Allergy and Rhinology 12/2013; 3(12). DOI:10.1002/alr.21222 · 2.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    Pharmacoepidemiology and Drug Safety 04/2014; 3(2):1-5. DOI:10.4172/2167-1052.1000148 · 3.17 Impact Factor